Enli Yang

485 total citations · 1 hit paper
6 papers, 364 citations indexed

About

Enli Yang is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Enli Yang has authored 6 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Oncology. Recurrent topics in Enli Yang's work include Vascular Malformations and Hemangiomas (2 papers), Extracellular vesicles in disease (2 papers) and Vascular Tumors and Angiosarcomas (2 papers). Enli Yang is often cited by papers focused on Vascular Malformations and Hemangiomas (2 papers), Extracellular vesicles in disease (2 papers) and Vascular Tumors and Angiosarcomas (2 papers). Enli Yang collaborates with scholars based in China. Enli Yang's co-authors include Dongsheng Zhang, Haiwei Wu, Zhiyuan Gong, Miao Yu, Xuan Wang, Zhanwei Chen, Mingyang Li, Shengyun Huang, Xuejian Liu and Yiming Li and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, Signal Transduction and Targeted Therapy and Cancer Science.

In The Last Decade

Enli Yang

6 papers receiving 362 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression

2020 340 citations Enli Yang, Xuan Wang et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Enli Yang China	4	285	200	71	52	40	6	364
Almut Eisele France	6	292 1.0×	187 0.9×	51 0.7×	35 0.7×	32 0.8×	6	374
Buwei Teng China	6	324 1.1×	234 1.2×	111 1.6×	60 1.2×	35 0.9×	8	408
Baoqing Tian China	11	347 1.2×	204 1.0×	45 0.6×	52 1.0×	57 1.4×	18	442
Kheng Wei Yeoh Singapore	6	227 0.8×	170 0.8×	122 1.7×	41 0.8×	30 0.8×	8	312
Hui Qian China	12	330 1.2×	231 1.2×	39 0.5×	47 0.9×	21 0.5×	17	432
Yanfeng Yin China	8	262 0.9×	197 1.0×	73 1.0×	50 1.0×	28 0.7×	8	361
Roman A. Zingarelli United States	4	304 1.1×	227 1.1×	54 0.8×	47 0.9×	53 1.3×	8	374
Maud-Emmanuelle Gilles United States	7	304 1.1×	229 1.1×	39 0.5×	52 1.0×	19 0.5×	7	373
Jiamei Feng China	5	288 1.0×	257 1.3×	49 0.7×	77 1.5×	36 0.9×	10	409

Countries citing papers authored by Enli Yang

Since Specialization

Citations

This map shows the geographic impact of Enli Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enli Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enli Yang more than expected).

Fields of papers citing papers by Enli Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enli Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enli Yang. The network helps show where Enli Yang may publish in the future.

Co-authorship network of co-authors of Enli Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Enli Yang. A scholar is included among the top collaborators of Enli Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enli Yang. Enli Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Huang, Shengyun, Li Ma, Mingyang Li, et al.. (2023). Propranolol-induced autophagic dysfunction combined with a targeted metal-organic framework as a novel strategy for improving antitumor therapeutic efficacy. Applied Materials Today. 33. 101886–101886. 3 indexed citations

2.

Li, Mingyang, Xuan Wang, Enli Yang, et al.. (2023). OTUB1 Catalytic-Independently Deubiquitinates TGFBI and Mediates the Angiogenesis in Infantile Hemangioma by Regulating Glycolysis. Arteriosclerosis Thrombosis and Vascular Biology. 43(5). 654–673. 10 indexed citations

3.

Wu, Haiwei, Zhiyuan Gong, Enli Yang, et al.. (2022). The anti-tumor effect of proteasome inhibitor MG132 for human adenoid cystic carcinoma: correlate with the emerging role of Nrf2/Keap1 signaling pathway. Head & Face Medicine. 18(1). 15–15. 1 indexed citations

4.

Yang, Enli, Xuan Wang, Shengyun Huang, et al.. (2022). Shikonin reverses pyruvate kinase isoform M2‐mediated propranolol resistance in infantile hemangioma through reactive oxygen species‐induced autophagic dysfunction. Cancer Science. 114(3). 806–821. 7 indexed citations

5.

Wang, Xuan, et al.. (2020). Biomechanical Analysis of Grafted and Nongrafted Maxillary Sinus Augmentation in the Atrophic Posterior Maxilla with Three-Dimensional Finite Element Method. Scanning. 2020. 1–8. 3 indexed citations

6.

Yang, Enli, Xuan Wang, Zhiyuan Gong, et al.. (2020). Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression. Signal Transduction and Targeted Therapy. 5(1). 242–242. 340 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact